论文信息 - Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia - 字舞流文

Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia

G. Efimov | D. Lioznov | T. Zhu | D. Lioznov | K. V. Zornikova | D. Zubkov | Y. Serdyuk | V. Dzutseva | I. Amosova | S. Sheetikov | M. Tsyferov | M. Khmelevskiĭ | A. Afansiev | N. Khomyakova | D. Zubkov | A. Tikhonov | L. Barreto | A. Tikhonov | K. Zornikova | Vitalina Dzutseva | Mikhail Tsyferov | Mikhail Khmelevskii | Andrei Afanasiev